OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue
Jan Kučera, Kateřina Horská, Pavel Hruška, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110165-110165
Closed Access | Times Cited: 14
Jan Kučera, Kateřina Horská, Pavel Hruška, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110165-110165
Closed Access | Times Cited: 14
Showing 14 citing articles:
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
Martina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel, et al.
Pharmacological Research (2020) Vol. 164, pp. 105357-105357
Open Access | Times Cited: 57
Martina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel, et al.
Pharmacological Research (2020) Vol. 164, pp. 105357-105357
Open Access | Times Cited: 57
Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease
Peter S. Spencer, Glen E. Kisby
Chemical Research in Toxicology (2021) Vol. 34, Iss. 9, pp. 1953-1969
Closed Access | Times Cited: 43
Peter S. Spencer, Glen E. Kisby
Chemical Research in Toxicology (2021) Vol. 34, Iss. 9, pp. 1953-1969
Closed Access | Times Cited: 43
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 29
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 29
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
Tibor Štark, Serena Di Martino, Filippo Drago, et al.
Pharmacological Research (2021) Vol. 174, pp. 105938-105938
Closed Access | Times Cited: 32
Tibor Štark, Serena Di Martino, Filippo Drago, et al.
Pharmacological Research (2021) Vol. 174, pp. 105938-105938
Closed Access | Times Cited: 32
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology
Martina Di Bartolomeo, Tibor Štark, Serena Di Martino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3907-3907
Open Access | Times Cited: 12
Martina Di Bartolomeo, Tibor Štark, Serena Di Martino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3907-3907
Open Access | Times Cited: 12
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model
Kateřina Horská, Silje Skrede, Jan Kučera, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3
Kateřina Horská, Silje Skrede, Jan Kučera, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats
Francesca Frescura, Tibor Štark, Edoardo Tiziani, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 887-894
Closed Access | Times Cited: 2
Francesca Frescura, Tibor Štark, Edoardo Tiziani, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 887-894
Closed Access | Times Cited: 2
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
Tibor Štark, Fabio Arturo Iannotti, Serena Di Martino, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 108-108
Open Access | Times Cited: 12
Tibor Štark, Fabio Arturo Iannotti, Serena Di Martino, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 108-108
Open Access | Times Cited: 12
GLP-1 agonists: superior for mind and body in antipsychotic-treated patients?
Kateřina Horská, Jana Kučerová, Silje Skrede
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 9, pp. 628-638
Closed Access | Times Cited: 9
Kateřina Horská, Jana Kučerová, Silje Skrede
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 9, pp. 628-638
Closed Access | Times Cited: 9
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia
Constanza Morén, Nina Treder, Albert Martínez-Pinteño, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2275-2275
Open Access | Times Cited: 8
Constanza Morén, Nina Treder, Albert Martínez-Pinteño, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2275-2275
Open Access | Times Cited: 8
Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model
Kateřina Horská, Jan Kučera, Eva Dražanová, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116763-116763
Open Access | Times Cited: 1
Kateřina Horská, Jan Kučera, Eva Dražanová, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116763-116763
Open Access | Times Cited: 1
Aberrant glycosylation in schizophrenia: insights into pathophysiological mechanisms and therapeutic potentials
Yanchen Feng, Lu Sun, Xue Dang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Yanchen Feng, Lu Sun, Xue Dang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
Milica Borovčanin, Katarina Vesić, Milena Jovanović, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 10, pp. 1731-1739
Open Access | Times Cited: 5
Milica Borovčanin, Katarina Vesić, Milena Jovanović, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 10, pp. 1731-1739
Open Access | Times Cited: 5
Weight gain and treatment with psychotropic drugs
Jakob Eder, Michael S. Simon, Catherine Glocker, et al.
Der Nervenarzt (2023) Vol. 94, Iss. 9, pp. 859-869
Closed Access
Jakob Eder, Michael S. Simon, Catherine Glocker, et al.
Der Nervenarzt (2023) Vol. 94, Iss. 9, pp. 859-869
Closed Access
